| FIXIX | IEGYX | FIXIX / IEGYX | |
| Total Expense Ratio | 1.04 | 1.30 | 80% |
| Annual Report Gross Expense Ratio | 1.04 | 1.43 | 73% |
| Fund Existence | 23 years | 17 years | - |
| Gain YTD | 20.351 | 10.660 | 191% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.38B | 670M | 803% |
| Annual Yield % from dividends | 2.11 | 1.31 | 161% |
| Returns for 1 year | 20.31 | 9.52 | 213% |
| Returns for 3 years | 44.48 | 21.88 | 203% |
| Returns for 5 years | 31.79 | 24.79 | 128% |
| Returns for 10 years | 78.69 | 64.64 | 122% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NDMO | 10.02 | 0.02 | +0.20% |
| Nuveen Dynamic Municipal Opportunities Fund | |||
| STXG | 51.56 | 0.08 | +0.16% |
| Strive 1000 Growth ETF | |||
| NBTR | 50.58 | N/A | N/A |
| Neuberger Berman Total Return Bond ETF | |||
| AVLV | 76.66 | -0.05 | -0.07% |
| Avantis US Large Cap Value ETF | |||
| FTXH | 33.49 | -0.04 | -0.13% |
| First Trust Nasdaq Pharmaceuticals ETF | |||